'Biosimilar market' presentation slideshows

Global Biosimilar Market Trends, Share, Size, Growth, Segment and Regional Forecast Till 2023

Get more information about the market: https://www.imarcgroup.com/biosimilar-market The global biosimilar market size was estimated to be US$ 2.9 Billion in 2017, growing at a CAGR of more than 36% during 2012-2017. Biosimilars, also known as subsequent entry biologics (SEBs) or follow-on biologics, refer to FDA-approved biotherapeutic products which are similar to their reference biologics. Biosimilars can only be manufactured after the patent of the reference product expires. Want more information about this market? Request a free report sample: https://www.imarcgroup.com/request?type=report&id=497&flag=B Contact Us IMARC Group James Smith Email: Sales@imarcgroup.com Tel No:(D) 91 120 433 0800 | http://www.imarcgroup.com Americas :- 1 631 791 1145 | Africa and Europe :- 44-702-409-7331 Linkedin: https://www.linkedin.com/company/imarc-group

155 views • 15 slides

Biosimilar Market Size Worth US$ 20.2 Billion by 2024 | CAGR 33%%

Get more information about the market: https://www.imarcgroup.com/biosimilar-market The global biosimilar market size was estimated to be US$ 3.8 Billion in 2018. Due to the abovementioned factors, the market is projected to expand at a CAGR of nearly 33% during 2019-2024, registering a value of US$ 20.2 Billion by 2024. Want more information about this market? Request a free report sample: https://www.imarcgroup.com/biosimilar-market/requestsample For India market research reports, visit: http://www.marketresearchindia.co.in Browse Related Report Biosimilar Market In Europe: https://www.imarcgroup.com/europe-biosimilar-market Oncology Biosimilar Market Report: https://www.imarcgroup.com/oncology-biosimilars-market Contact Us IMARC Group James Smith Email: Sales@imarcgroup.com Tel No:(D) 91 120 433 0800 | https://www.imarcgroup.com Americas :- 1 631 791 1145 | Africa and Europe :- 44-702-409-7331 Linkedin: https://www.linkedin.com/company/imarc-group

134 views • 13 slides

Biopreservation Market Research Report, Market Share, Size, Trends, Forecast and Analysis of Key Players 2024

Get more information about the market: https://www.imarcgroup.com/biopreservation-market The global biopreservation market reached a value of US$ 2.8 Billion in 2018. The report further anticipates the market value to reach US$ 4.8 Billion by 2024, at a projected CAGR of 9.8% over the forecast period. Want more information about this market? Request a free report sample: https://www.imarcgroup.com/biopreservation-market/requestsample For India market research reports, visit: http://www.marketresearchindia.co.in Browse Related Report Biosimilar Market in Europe: https://www.imarcgroup.com/europe-biosimilar-market Biosimilar Market Report: https://www.imarcgroup.com/biosimilar-market Contact Us IMARC Group James Smith Email: Sales@imarcgroup.com Tel No:(D) 91 120 433 0800 | https://www.imarcgroup.com Americas :- 1 631 791 1145 | Africa and Europe :- 44-702-409-7331 Linkedin: https://www.linkedin.com/company/imarc-group

112 views • 11 slides

Latest Chinese Guidance for Development, Evaluation, License

Latest Chinese Guidance for Development, Evaluation, License Approval of Biosimilars provided a comprehensive and thorough knowledge of the latest Chinese guidance for development, evaluation, license approval of biosimilars and guide you use the Chinese trial venues to keep biosimilars development lean and to smoothly operate in China. To know more : https://www.bharatbook.com/healthcare-market-research-reports-185839/chinese-guidance-development-evaluation-license-approval-biosimilars.html

321 views • 8 slides

Global Biosimilar Market 2018 Analysis By Top Key Players - Sandoz International GmbH, Pfizer Inc., Teva Pharmaceutical

85 views • 8 slides

Biosimilar Market in Europe Overview 2018, Demand by Regions, Share, Trends, Growth and Forecast to 2023

Get more information about the market: http://bit.ly/2yHrbqR The biosimilar market in Europe reached a value of US$ 2,013 Million in 2017. Biosimilars refer to biological drugs which are highly similar to already approved branded drugs in terms of safety, efficacy, structure, immunogenicity profile, etc. Want more information about this market? Request a free report sample: https://www.imarcgroup.com/request?type=report&id=1023&flag=B Contact Us IMARC Group USA: 1-631-791-1145 Email: sales@imarcgroup.com Website: https://www.imarcgroup.com Follow us on twitter : @imarcglobal

86 views • 8 slides

Key Analysis Of Biosimilars Development Market

197 views • 7 slides

Latest Chinese Guidance for Development, Evaluation, License Approval of Biosimilars

China has an indispensable biosimilar market for overseas and multinational pharmaceutical companies. Historical data shows 40 per cent of China's $1.5bn recombinant biologic product sales come from biosimilars, which have enjoyed approximately 25-30 per cent CAGR over the past decade. If the market continues to grow at 25 per cent per year, the biosimilar market could grow to $2bn, around 20 per cent of the global biosimilar market by 2015. It is attracting more and more overseas and multinational pharmaceutical manufacturers and producers to penetrate such market.

258 views • 7 slides

Latest Regulations on Pharmaceutical International Multi-Center Clinical Trials in China

This is first time in history, Chinese pharmaceutical authorities officially issued a guidance on international multi-center clinical trials of drugs in China, which has begun to be implemented on March 1, 2015. The guidance provides an opportunity to reduce risk from the examination uncertainty and approval delays to eat up your time and energy to achieve a successful entry into such a lucrative drug market, and to avoid trouble for your business smoothly in China. The overseas and multinational pharmaceutical manufacturers must be compliance with the latest regulations.

250 views • 7 slides

Global Biosimilar Pipeline and Market Research Report 2017

Global Biosimilar Pipeline and Market Research Report provides an in-depth assessment of the current trends in the global biosimilar market, with a particular focus on manufacturing complexities and the strategies being implemented to overcome them. This report also assesses the state of the biosimilar R&D and commercial landscape through multilevel analytics. For more detail click the Official URL below https://goo.gl/93gSKM

107 views • 6 slides

Global Biosimilars Market 2018: Adroit Market Research

The scope of the Biosimilars Market report includes a detailed study of global and regional markets and Identify the growth segment and apportunity in the industry.

64 views • 6 slides

Biosimilars Market Overview in 2015 Research Report

341 views • 5 slides

Dubai International Pharmaceutical & Technology Conference & Exhibition

https://duphat.ae/the-biosimilars-scenario-in-the-mena-region/ The Biosimilars scenario in the MENA Region Biosimilars, a cost-effective alternative to expensive biologics, have emerged to become a viable solution to the patient access barrier which impacted earlier in case of biologics. Biosimilars are increasingly becoming popular for treating a wide range of life-threatening diseases and represent a rapidly expanding segment of pharmaceutical industry.

34 views • 3 slides